The purpose of this study is to establish a comprehensive set of dose measurements data obtained from the X-ray Volumetric Imager (XVI, Elekta Oncology Systems) and the On-Board Imager (OBI, Varian Medical Systems) cone-beam CT (CBCT) systems. To this end, two uniform-density cylindrical acrylic phantoms with diameters of 18 cm (head phantom) and 30 cm (body phantom) were used for all measurements. Both phantoms included ion chamber placement holes in the center and at periphery (2 cm below surface). For the XVI unit, the four standard manufacturer-supplied protocols were measured. For the OBI unit, the full bow tie and half bow tie (and no bow tie) filters were used in combination with the two scanning modes; namely, full-fan and half-fan. The total milliampere x seconds (mA s) setting was also varied for each protocol to establish the linear relationship between the dose deposited and the mA s used (with all other factors being held constant). Half-value layers in aluminum (Al) were also measured for beam characteristic determination. For the XVI unit, the average dose ranged from 0.1 to 3.5 cGy with the highest dose measured using the "prostate" protocol with the body phantom. For the OBI unit, the average dose ranged from 1.1 to 8.3 cGy with the highest dose measured using the full-fan protocol with the head phantom. The measured doses were highly linear as a function of mA s, for both units, where the measurement points followed a linear relationship very closely with R2 > 0.99 for all cases. Half-value layers were between 4.6- and 7.0-mm-Al for the two CBCT units where XVI generally had more penetrating beams at the similar kVp settings. In conclusion, a comprehensive series of dose measurements were performed on the XVI and the OBI CBCT units. In the process, many of the important similarities and differences between the two systems were observed and summarized in this work.
The purpose of this note is to evaluate the relationship between the stochastic errors in CT numbers and the standard deviation of the computed proton beam range in radiotherapy planning. The stochastic voxel-to-voxel variation in CT numbers called 'noise,' may be due to signal registration, processing and numerical image reconstruction technique. Noise in CT images may cause a deviation in the computed proton range from the physical proton range, even assuming that the error due to CT number-stopping power calibration is removed. To obtain the probability density function (PDF) of the computed proton range, we have used the continuing slowing down approximation (CSDA) and the uncorrelated white Gaussian noise along the proton path. The model of white noise was accepted because for the slice-based fan-beam CT scanner; the power-spectrum properties apply only to the axial (x, y) domain and the noise is uncorrelated in the z domain. However, the possible influence of the noise power spectrum on the standard deviation of the range should be investigated in the future. A random number generator was utilized for noise simulation and this procedure was iteratively repeated to obtain convergence of range PDF, which approached a Gaussian distribution. We showed that the standard deviation of the range, sigma, increases linearly with the initial proton energy, computational grid size and standard deviation of the voxel values. The 95% confidence interval width of the range PDF, which is defined as 4sigma, may reach 0.6 cm for the initial proton energy of 200 MeV, computational grid 0.25 cm and 5% standard deviation of CT voxel values. Our results show that the range uncertainty due to random errors in CT numbers may be significant and comparable to the uncertainties due to calibration of CT numbers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.